A Feasibility Study of Bevacizumab Plus Dose-Dense Doxorubicin-Cyclophosphamide (AC) Followed by Nanoparticle Albumin-Bound Paclitaxel in Early-Stage Breast Cancer
Clinical Cancer Research - United States
doi 10.1158/1078-0432.ccr-10-1969
Full Text
Open PDFAbstract
Available in full text
Date
February 24, 2011
Authors
Publisher
American Association for Cancer Research (AACR)